Navigation Links
MIT model helps researchers 'see' brain development

Large mammals--humans, monkeys, and even cats--have brains with a somewhat mysterious feature: The outermost layer has a folded surface. Understanding the functional significance of these folds is one of the big open questions in neuroscience.

Now a team led by MIT, Massachusetts General Hospital and Harvard Medical School researchers has developed a tool that could aid such studies by helping researchers “see?how those folds develop and decay in the cerebral cortex.

By applying computer graphics techniques to brain images collected using magnetic resonance (MR) imaging, they have created a set of tools for tracking and measuring these folds over time. Their resulting model of cortical development may serve as a biomarker, or biological indicator, for early diagnosis of neurological disorders such as autism.

The researchers describe their model and analysis in the April issue of IEEE Transactions on Medical Imaging.

Peng Yu, a graduate student in the Harvard-MIT Division of Health Sciences and Technology (HST), is first author on the paper. The work was led by co-author Bruce Fischl, associate professor of radiology at Harvard Medical School, research affiliate with the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) and HST, and director of the computational core at the HST Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH).

The team started with a collection of MR images from 11 developing brains, provided by Ellen Grant, chief of pediatric radiology at MGH and the Martinos Center. Of the subjects scanned, eight were newborn, mostly premature babies ranging from about 30 to 40 weeks of gestational age, and three were from children aged two, three and seven years. Grant scanned these infants and children to assess possible brain injury and found no neural defects. Later, she also consulted with Fischl's team to ensure that their analyses made sense clinically.

“We can't open the brain and see by eye, but the cool thing we can do now is see through the MR machine,?a technology that is much safer than earlier techniques such as X-ray imaging, said Yu.

The first step in analyzing these images is to align their common anatomical structures, such as the “central sulcus,?a fold that separates the motor cortex from the somatosensory cortex. Yu applied a technique developed by Fischl to perform this alignment.

The second step involves modeling the folds of the brain mathematically in a way that allows the researchers to analyze their changes over time and space.

The original brain scan is then represented computationally with points. Charting each baby's brain requires about 130,000 points per hemisphere. Yu decomposed these points into a representation using just 42 points that shows only the coarsest folds. By adding more points, she created increasingly finer-grained domains of smaller, higher-resolution folds.

Finally, Yu modeled biological growth using a technique recommended by Grant that allowed her to identify the age at which each type of fold, coarse or fine, developed, and how quickly.

She found that the coarse folds, equivalent to the largest folds in a crumpled piece of paper, develop earlier and more slowly than fine-grained folds.

In addition to providing insights into cortical development, the team is now comparing the images to those being collected from patients with autism. “We now have some idea of what normal development looks like. The next step is to see if we can detect abnormal development in diseases like autism by looking at folding differences,?said Fischl. This tool may also be used to shed light on other neurological diseases such as schizophrenia and Alzheimer's disease.


Source:Massachusetts Institute of Technology

Related biology news :

1. Scientists identify new model Of NK cell development
2. Genrate: a generative model that finds and scores new genes and exons in genomic microarray data
3. Molecular models advance the fight against malaria
4. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
5. Genetic therapy reverses nervous system damage in animal model of inherited human disease
6. Disease progression model of pancreatic cancer developed by Penn researchers
7. A new way to share models of biological systems
8. Understanding biases in epidemic models important when making public health predictions
9. Climate model links higher temperatures to prehistoric extinction
10. Gene therapy advance treats hemophilia in mouse models
11. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
Post Your Comments:

(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology: